Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Chubb

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Trends in Biotechnology|April 1, 1992
Human therapeutics based on triple helix technologyJ M Chubb, M E Hogan
The Journal of Urology|September 1, 1983
Ceftazidime, an open randomized comparison of 3 dosages for genitourinary infectionsS J Childs, W G Wells, J M Chubb
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1978
Effects of praziquantel, a new anthelmintic, on electromechanical properties of isolated rat atriaJ M Chubb, J L Bennett, T Akera, et al.
Biopharmaceutics & Drug Disposition|November 1, 1988
Relative bioavailability of a controlled-release albuterol formulation for twice-daily useR S Sykes, M E Reese, M C Meyer, et al.
Biochemical and Biophysical Research Communications|December 6, 1976
Increase in type I adenosine 3',5'-monophosphate-dependent protein kinase during isoproterenol-induced cardiac hypertrophyC V Byus, J M Chubb, R J Huxtable, et al.
Angiology|May 1, 1986
Effects of ethaverine hydrochloride on the walking tolerance of patients with intermittent claudicationF S Trainor, R E Phillips, D D Michie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1989
GR 38032F (GR-C507/75): a novel compound effective in the prevention of acute cisplatin-induced emesisP J Hesketh, W K Murphy, E P Lester, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Trends in Biotechnology|April 1, 1992
Human therapeutics based on triple helix technologyJ M Chubb, M E Hogan
The Journal of Urology|September 1, 1983
Ceftazidime, an open randomized comparison of 3 dosages for genitourinary infectionsS J Childs, W G Wells, J M Chubb
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1978
Effects of praziquantel, a new anthelmintic, on electromechanical properties of isolated rat atriaJ M Chubb, J L Bennett, T Akera, et al.
Biopharmaceutics & Drug Disposition|November 1, 1988
Relative bioavailability of a controlled-release albuterol formulation for twice-daily useR S Sykes, M E Reese, M C Meyer, et al.
Biochemical and Biophysical Research Communications|December 6, 1976
Increase in type I adenosine 3',5'-monophosphate-dependent protein kinase during isoproterenol-induced cardiac hypertrophyC V Byus, J M Chubb, R J Huxtable, et al.
Angiology|May 1, 1986
Effects of ethaverine hydrochloride on the walking tolerance of patients with intermittent claudicationF S Trainor, R E Phillips, D D Michie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1989
GR 38032F (GR-C507/75): a novel compound effective in the prevention of acute cisplatin-induced emesisP J Hesketh, W K Murphy, E P Lester, et al.
Pageof 1